Recursion director proposes $242K share sale

The notice also lists three Class A sales by the director from July 7 through September 1, 2026.

Rhea-AI Filing Summary

Recursion Pharmaceuticals, Inc. (RXRX) reports that Director Blake C. Borgeson intends to sell 50,000 Class A shares through Fidelity Brokerage Services LLC, at an aggregate market value of $242,000.00. The notice gives October 6, 2026, as the approximate sale date. It also lists three Class A sales by Borgeson during the preceding three months: 40,000 shares on July 7, 2026; 30,000 on August 4, 2026; and 30,000 on September 1, 2026.

Key Figures

Proposed sale: 50,000 Class A shares Aggregate market value: $242,000.00 July 7, 2026 sale: 40,000 Class A shares +5 more

8 metrics

Proposed sale 50,000 Class A shares Approximate sale date: October 6, 2026

Aggregate market value $242,000.00 Proposed sale of Class A shares

July 7, 2026 sale 40,000 Class A shares Reported sale

Sale value $158,500.00 July 7, 2026 sale

August 4, 2026 sale 30,000 Class A shares Reported sale

Sale value $97,500.00 August 4, 2026 sale

September 1, 2026 sale 30,000 Class A shares Reported sale

Sale value $100,200.00 September 1, 2026 sale

Key Terms

Rule 144, Founders shares, Securities To Be Sold

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Founders shares financial

"Class A | 09/19/2017 | Founders shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

Securities To Be Sold financial

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RXRX shares does director Blake C. Borgeson plan to sell?

Director Blake C. Borgeson reported a proposed sale of 50,000 Class A shares through Fidelity Brokerage Services LLC, with an aggregate market value of $242,000.00. The notice gives October 6, 2026, as the approximate sale date.

What RXRX shares did Blake C. Borgeson sell in the prior three months?

During the three months before the notice, Blake C. Borgeson reported selling 40,000 Class A shares on July 7, 2026, for $158,500.00; 30,000 shares on August 4, 2026, for $97,500.00; and 30,000 shares on September 1, 2026, for $100,200.00.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/06/2026 - 11:48 AM Accepted by SEC EDGAR 10/06/2026 - 11:48 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001856094
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RECURSION PHARMACEUTICALS, INC.
SEC File Number	001-40323
Address of Issuer	41S RIO GRANDE STREET SALT LAKE CITY UTAH 84101
Phone	(385) 269-0203
Name of Person for Whose Account the Securities are To Be Sold	Borgeson Blake
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	50000	242000.00	535342170	10/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/19/2017	Founders shares	Issuer			50000	09/17/2017	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Blake C. Borgeson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	07/07/2026	40000	158500.00
Blake C. Borgeson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	08/04/2026	30000	97500.00
Blake C. Borgeson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	09/01/2026	30000	100200.00

144: Remarks and Signature

Remarks
Date of Notice	10/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/31/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Blake C. Borgeson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)